Basic Information
ID: ALA4052096
Type: Binding
Description: Modulation of patient derived full length SMN2 pre mRNA splicing assessed as inclusion of exon 7
Format: BAO_0000019
Organism: Homo sapiens
Target: Unchecked(ALA612545)
Document: ALA4049449
Modulation of patient derived full length SMN2 pre mRNA splicing assessed as inclusion of exon 7: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4052096
EC1.5
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 378.48 | 2.37 | 2.37 |
| 386.41 | 2.37 | 2.37 |
| 388.83 | 2.49 | 2.49 |
| 381.46 | 3.14 | 3.14 |
| 382.44 | 2.54 | 2.54 |
| 367.41 | 1.10 | 1.10 |
| 383.43 | 1.93 | 1.93 |
| 349.44 | 3.07 | 3.07 |
| 375.48 | 2.76 | 2.76 |
| 382.44 | 2.62 | 2.62 |
| 367.43 | 3.16 | 3.16 |
| 382.44 | 2.62 | 2.62 |
| 368.42 | 2.23 | 2.23 |
| 371.39 | 2.58 | 2.58 |
| 386.41 | 2.37 | 2.37 |
| 389.46 | 2.87 | 2.87 |
| 345.45 | 2.50 | 2.50 |
| 364.45 | 2.35 | 2.35 |
| 337.43 | 2.33 | 2.33 |
| 354.39 | 1.84 | 1.84 |
| 382.44 | 2.49 | 2.49 |
| 363.47 | 3.29 | 3.29 |
| 363.47 | 3.41 | 3.41 |
| 350.43 | 2.01 | 2.01 |
| 336.40 | 1.70 | 1.70 |
| 372.38 | 3.08 | 3.08 |
| 380.45 | 2.10 | 2.10 |
| 382.44 | 2.62 | 2.62 |
| 422.51 | 3.41 | 3.41 |
| 377.45 | 3.08 | 3.08 |
| 363.47 | 2.84 | 2.84 |
| 333.44 | 2.93 | 2.93 |
| 396.47 | 2.86 | 2.86 |
| 335.46 | 2.54 | 2.54 |
| 437.52 | 2.87 | 2.87 |
| 364.45 | 2.79 | 2.79 |
| 364.45 | 2.35 | 2.35 |